Skip to main content
Fig. 4 | Cancer Imaging

Fig. 4

From: Early evaluation of liver metastasis using spectral CT to predict outcome in patients with colorectal cancer treated with FOLFOXIRI and bevacizumab

Fig. 4

Baseline contrast-enhanced CT, spectral CT within 2 months, and contrast-enhanced CT at 6-month in R − and R + patients. A-C. For R − patients, the mean value of IoD was 4.86 (100ug/cm3). D-F. For R + patients, the mean value of IoD was 3.85 (100ug/cm3)

Back to article page